NCRM NICHE 2018 will be held in Tokyo, Japan on 21st, 22nd & 23rd October 2018 . Online registrations are now open.

PROFILE OF SPEAKERS

Prof. Dr. Jun Hirabayashi
National Institute of Advanced Industrial Science and Technology (AIST), Biotechnology Research Institute for Drug Discovery (BRD), Japan

Prof. Dr. Jun Hirabayashi is the Prime senior researcher of Biotechnology Research Institute for Drug Discovery at the National Institute of Advanced Industrial Science and Technology (AIST), Japan. He also serves as the Director of Japan Consortium for Glycoscience and Glycotechnology (JCGG) and Councilor, The Japanese Society of Carbohydrate Research (JSCR). His main research fields include Biochemistry, Glycoscience, Glycotechnology and Lectin Engineering. Dr. Hirabayashi's achievements include him being the first to report a covalent primary structure of B-galactoside binding from embryonic chick and was involved in the naming of this family of protein, i.e., galectins. Also, he cloned a cDNA for human galectin-1 and expressed it as a recombinant protein for the first time. Dr. Hirabayashi is also the inventor of "slalom chromatography", which is a novel separation phenomenon accidentally observed for relatively large DNA (>10 kbp) when attempting phage DNA purification to exclude smaller RNA molecules by means of gel-permeation chromatography. Dr. Hirabayashi also developed a unique lectin affinity-capturing method named "glyco-catch" which was later up-graded to a more sophisticated system by his collaborators. Before developing these advanced analytical systems, he has had strongly in mind "Glycomics, coming of age" in the 21st Century, and proposed Glycome Project on the stage of C. elegans (the first multicellular organism, of which genome was determined) in the occasion of GlycoXV, International Symposium on Glycoconjugates held in Tokyo in 1999 .With these achievements evaluated highly, Dr. Hirabayashi moved in November, 2002 by invitation to AIST, the biggest national institute in Japan, and was responsible to development of a new glycan profiling system under the national project Structural Glycomics.